Adam Levy

Mr. Levy has over twenty years of operational and transactional experience in biotech and investment banking. Prior to joining Mineralys, he was the Chief Financial Officer at Sanifit Therapeutics until the Company was acquired by Vifor Pharma in 2022. Previously, Adam served as the Chief Business Officer at Brickell Biotech and led the organization’s financial operations transition as it became a publicly listed company on the Nasdaq. Before joining Brickell, he also served as the Chief Business officer at miRagen therapeutics where he was responsible for a variety of functions including financial strategy, investor relations, business development, legal affairs, intellectual property, project and program management, and human resources. Adam successfully guided miRagen through multiple capital raises and a listing on the Nasdaq. Between 2000 and 2016, Mr. Levy held multiple Investment Banking Positions at Merrill Lynch, Jefferies Group and Wedbush Securities. During his time as an investment banker, he completed over $30 Billion in financings and M&A transactions for his clients. Adam received a B.S. in Applied Economics from Cornell University.